The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the… Read More »Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
initial public offering
What You Should Know: – Digital health company Sharecare and special purpose acquisition company (SPAC), Falcon Capital Acquisition Corp, today announced an agreement to merge to go public on the NASDAQ under the ticker symbol SHCR at enterprise value of $3.9B. – The transaction is… Read More »Sharecare to Go Public in SPAC IPO Deal, Reaching $3.9B Valuation
What You Should Know: – Shares of Signify Health, a value-based care billing platform for in-home and bundled health services jumped more than 33% in its initial public offering (IPO), valuing the company at over $7.12B. – Today, Signify Health’s CEO Kyle Armbrester will also… Read More »Signify Health Shares Soar More Than 33% in IPO, Valuing Company at Over $7.12B
Compute Health Acquisition Corp Chairman Omar Ishrak What You Should Know: – Compute Health Acquisition, a SPAC company targeting the intersection of computation and healthcare announced the pricing of its $750M initial public offering (IPO) by offering 75 million units at $10. Compute Health Acquisition… Read More »SPAC Compute Health Acquisition Prices $750M IPO, Led by Intel Chairman
What You Should Know: – Israeli-based G Medical Innovation has withdrawn its plans for an initial public offering (IPO) on Tuesday, Nasdaq first reports. – The company originally filed an IPO to raise $30 million by offering 5 million shares at a price range of… Read More »Israeli Digital Health Startup G Medical Innovations Withdraws $30M US IPO
With its share price falling from more than $66 to less than $24, September was a tumultuous month for Nanox. On August 25th, the medical imaging start-up closed its initial public offering, having raised $190m from the sale of 10,555,556 ordinary shares at a price… Read More »Will Nanox Disrupt The X-ray Systems Market?
The company, whose drug-discovery efforts are focused on protein motion and detection of interactions that occur anywhere on a protein rather than only at active sites, filed to go public last month.